Low glycemic sugar composition
AssigneeSweet Sense Inc.
InventorDaryl Thompson
Life of this patent
Estimating the term…
Abstract
A composition includes a sugar source and inositol. The sugar source is one more sugars select from the group consisting of glucose, sucrose, sucralose, tagatose, galactose, high fructose corn syrup, fructose, isoglucose, and rhamnose. The composition of sugar and inositol has an unique properties that prevents or limits the signaling of TNF-α and associated pro-inflammatory cytokines when metabolized by an individual consuming the composition. Accordingly, the composition can be advantageously used to control blood glucose levels, treat diabetes and related conditions as well as treat diseases based on an inflammatory response.
Claims27
A composition consisting of an effective amount of a sugar and myo inositol wherein the sugar is selected from one or more of sucrose, a fructose, isoglucose, and galactose;
- and the composition mitigates a TNF-α response to the sugar.
A composition consisting essentially of an effective amount of a sugar and myo-inositol with anti-TNF-α effects when administered to a patient in need of the anti-TNF-α effect,
- wherein the composition mitigates a TNF-α response to the sugar.
Dependencies are inferred from the claim text.